These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12561255)

  • 1. Describing solubility of polymorphs in mixed solvents by CNIBS/R-K equation.
    Jouyban A; Clark BJ
    Pharmazie; 2002 Dec; 57(12):861-2. PubMed ID: 12561255
    [No Abstract]   [Full Text] [Related]  

  • 2. Deviations of drug solubility in water-cosolvent mixtures from the Jouyban-Acree model--effect of solute structure.
    Jouyban A; Fakhree MA; Ghafourian T; Saei AA; Acree WE
    Pharmazie; 2008 Feb; 63(2):113-21. PubMed ID: 18380397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction of drug solubility in water-dioxane mixtures using the Jouyban-Acree model.
    Jouyban A
    Pharmazie; 2007 Jan; 62(1):46-50. PubMed ID: 17294813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of aqueous solubility estimation from AQUAFAC and the GSE.
    Jain P; Sepassi K; Yalkowsky SH
    Int J Pharm; 2008 Aug; 360(1-2):122-47. PubMed ID: 18514447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic study of the transformation of mefenamic acid polymorphs in various solvents and under high humidity conditions.
    Kato F; Otsuka M; Matsuda Y
    Int J Pharm; 2006 Sep; 321(1-2):18-26. PubMed ID: 16765543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of various cosolvency models for calculating solute solubility in water-cosolvent mixtures.
    Jouyban-Gharamaleki A; Valaee L; Barzegar-Jalali M; Clark BJ; Acree WE
    Int J Pharm; 1999 Jan; 177(1):93-101. PubMed ID: 10205606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds.
    Nordström FL; Rasmuson AC
    Eur J Pharm Sci; 2009 Feb; 36(2-3):330-44. PubMed ID: 19022383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
    Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
    Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical methods for assay of ellagic acid and its solubility studies.
    Bala I; Bhardwaj V; Hariharan S; Kumar MN
    J Pharm Biomed Anal; 2006 Jan; 40(1):206-10. PubMed ID: 16111850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.
    Romero S; Escalera B; Bustamante P
    Int J Pharm; 1999 Feb; 178(2):193-202. PubMed ID: 10205639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility of drugs in aqueous solutions. Part 4. Drug solubility by the dilute approximation.
    Ruckenstein E; Shulgin I
    Int J Pharm; 2004 Jul; 278(2):221-9. PubMed ID: 15196627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in solubility of polymorphs.
    Pudipeddi M; Serajuddin AT
    J Pharm Sci; 2005 May; 94(5):929-39. PubMed ID: 15770643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug solubility in ternary solvent mixture.
    Jouyban-Gharamaleki A; Clark BJ; Acree WE
    Drug Dev Ind Pharm; 2000 Sep; 26(9):971-3. PubMed ID: 10914321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility of drugs in aqueous solutions. Part 3: multicomponent mixed solvent.
    Ruckenstein E; Shulgin I
    Int J Pharm; 2003 Nov; 267(1-2):121-7. PubMed ID: 14602390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-solubilization of poorly soluble drugs by micellization and complexation.
    Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K
    Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.